Free Trial

Hyperfine (HYPR) Competitors

$0.84
-0.02 (-2.34%)
(As of 05/31/2024 ET)

HYPR vs. SMLR, EDAP, OM, ELMD, FONR, VANI, CUTR, POCI, IRIX, and ECOR

Should you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Semler Scientific (SMLR), Edap Tms (EDAP), Outset Medical (OM), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Cutera (CUTR), Precision Optics (POCI), IRIDEX (IRIX), and electroCore (ECOR). These companies are all part of the "electromedical equipment" industry.

Hyperfine vs.

Hyperfine (NASDAQ:HYPR) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Semler Scientific has a net margin of 32.92% compared to Hyperfine's net margin of -358.59%. Semler Scientific's return on equity of 30.36% beat Hyperfine's return on equity.

Company Net Margins Return on Equity Return on Assets
Hyperfine-358.59% -46.96% -42.42%
Semler Scientific 32.92%30.36%27.38%

Hyperfine received 3 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 50.00% of users gave Semler Scientific an outperform vote while only 44.44% of users gave Hyperfine an outperform vote.

CompanyUnderperformOutperform
HyperfineOutperform Votes
4
44.44%
Underperform Votes
5
55.56%
Semler ScientificOutperform Votes
1
50.00%
Underperform Votes
1
50.00%

15.0% of Hyperfine shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 29.4% of Hyperfine shares are held by company insiders. Comparatively, 13.0% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Hyperfine has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500.

Hyperfine presently has a consensus price target of $2.12, indicating a potential upside of 153.19%. Given Hyperfine's higher probable upside, research analysts plainly believe Hyperfine is more favorable than Semler Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Semler Scientific has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hyperfine$11.69M5.14-$44.24M-$0.59-1.42
Semler Scientific$68.18M3.04$20.58M$2.7910.51

In the previous week, Semler Scientific had 8 more articles in the media than Hyperfine. MarketBeat recorded 10 mentions for Semler Scientific and 2 mentions for Hyperfine. Hyperfine's average media sentiment score of 0.96 beat Semler Scientific's score of 0.52 indicating that Hyperfine is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hyperfine
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Semler Scientific
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

Semler Scientific beats Hyperfine on 13 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HYPR vs. The Competition

MetricHyperfineElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$60.15M$3.25B$5.13B$7.96B
Dividend YieldN/A1.69%2.75%4.01%
P/E Ratio-1.429.63167.1718.57
Price / Sales5.1472.162,418.7891.65
Price / CashN/A68.9035.3031.51
Price / Book0.804.165.534.59
Net Income-$44.24M$86.13M$106.01M$213.90M
7 Day Performance-4.89%-1.51%1.14%0.87%
1 Month Performance4.36%2.15%1.43%3.60%
1 Year Performance-50.82%-9.15%4.07%7.91%

Hyperfine Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
0 of 5 stars
$29.04
-9.9%
N/A+6.1%$227.80M$68.18M10.4192Short Interest ↓
Gap Up
High Trading Volume
EDAP
Edap Tms
3.0005 of 5 stars
$5.77
-1.7%
$14.00
+142.6%
-40.7%$217.80M$65.42M-10.68307Short Interest ↓
Positive News
OM
Outset Medical
1.4754 of 5 stars
$3.54
-6.8%
$5.42
+53.0%
-82.9%$196.54M$130.38M-1.05480Positive News
ELMD
Electromed
0 of 5 stars
$14.79
+0.7%
N/AN/A$127.15M$48.07M29.58170
FONR
FONAR
0 of 5 stars
$15.56
+1.9%
N/A-8.3%$96.63M$98.64M8.46561Upcoming Earnings
Short Interest ↓
Positive News
VANI
Vivani Medical
0 of 5 stars
$1.64
flat
N/A+23.5%$90.17MN/A-3.2844
CUTR
Cutera
1.8384 of 5 stars
$2.08
-7.6%
$12.67
+509.0%
-87.3%$45.16M$212.37M-0.29540Positive News
POCI
Precision Optics
0 of 5 stars
$6.54
-5.2%
N/A-6.8%$41.87M$21.05M-23.3684Short Interest ↓
Positive News
IRIX
IRIDEX
0.1877 of 5 stars
$2.47
+2.1%
$2.00
-19.0%
+12.5%$39.33M$51.87M-3.69111Analyst Forecast
ECOR
electroCore
0.4379 of 5 stars
$6.56
+0.8%
N/A+33.4%$39.10M$16.03M-2.3068Short Interest ↑
Gap Up

Related Companies and Tools

This page (NASDAQ:HYPR) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners